Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02779127
Other study ID # 07 269 03
Secondary ID
Status Completed
Phase N/A
First received March 9, 2016
Last updated April 14, 2017
Start date December 2007
Est. completion date June 2008

Study information

Verified date April 2017
Source University Hospital, Toulouse
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Endothelium is considered a real member, so it is contributing to determine the vascular homeostasis. The presence of endothelial dysfunction, evaluated in peripheral arteries by non-invasive study of the variation of gauge of the brachial artery as a result of post-ischemic hyperemia (FMD), is predictive of occurrence of major cardiovascular events. Several recent studies have shown that passive smoking is correlated with endothelial dysfunction and, therefore, non-smokers exposed subjects to passive smoking, have an increased risk of occurrence cardiovascular pathologies. From January 2008, a ministerial decree will ban smoking in bars, restaurants and nightclubs. The impact of exposure end to smoking in non-smoking subjects, as part of a prospective study and controlled, has never been evaluated.


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date June 2008
Est. primary completion date June 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Subject exposed at least one hour per day to passive smoking at work during at 1 year minimum for intervention arm and non exposed to passive smoking for control group.

- Subject having signed informed consent

- Subject with social security insurance or equivalent

Exclusion Criteria:

- Exposition to passive smoking at home

- Active smokers (at least 1 cigarette per day or having drawn up active smoking for less than a month)

- Medical history of homozygote familial hypercholesterolemia

- Usage of lipid lowering treatment in the month before the inclusion

- Hepatic active pathology or hepatocellular insufficiency

- Severe kidney disease (with creatine clearance less than 30 ml per minute)

- Evolutive cancer

- Usage of concomitant treatment as : insulin, nitro-derivatives and statins

- Medical history of alcoholism or drug use last year

- Medical history of permanent systolic hypotension (systolic blood pressure less than 90 mmHg) or non controled hypertension (systolic blood pressure higher than 200 mmHg and diastolic blood pressure 110 mmHg)

- Active cardiovascular disease

- Psychological or medical conditions incompatible with the study according to investigator opinion

- Participation to another study with experimental product or subject having received an study treatment within 4 weeks before inclusion

- Impossibility to follow the study procedure

- Pregnancy and breastfeeding

- Subject protected by french law

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Medical interrogatory
Cardiovascular risk, medical history, known pathologies and actual treatments are evaluated
Medical examination
Systolic blood pressure, diastolic blood pressure, cardiac frequency, pulse palpation, hearth and pulmonary auscultation
Specific bioassay
Exhaled carbon monoxide measure and nicotine in the urine are evaluated
Endothelial function evaluation
Endothelial function evaluation done by echotracking determining the basale flow mediated dilatation
General bioassay
Fasting bioassay evaluating total cholesterol, low density lipoproteins, high density lipoproteins, triglycerides, creatine, transaminases, gamma glutamyl transferases, fibrinogen, reactive protein C, blood count and sedimentation rate.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Toulouse

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of Endothelial function between two groups of non smoking workers exposed or not to passive smoking at work before and after interdiction of smoking decree as assessed by mean change in dilatation percentage of brachial artery. Percentage of dilation of the brachial artery after test ischemia will be compared at the start and at the end of the study (Day 90) change between Day 0 and Day 90
Secondary Determination of flow mediated dilatation in non smokers patient as assessed by mean change in dilatation percentage of brachial artery. change between Day 0 and Day 90
See also
  Status Clinical Trial Phase
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02649556 - A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 N/A
Completed NCT03901066 - Smoking Dependence and Periodontitis
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Completed NCT03305978 - Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan. N/A
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT06105424 - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability N/A
Active, not recruiting NCT02752022 - Monitoring the Transition From Smoking to E-cigarettes
Completed NCT04340830 - The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02901171 - The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation N/A
Completed NCT02912000 - TEACH: Technology Evaluation to Address Child Health N/A
Completed NCT02949648 - Electronic Cigarette Use and Quitting in Youth N/A
Completed NCT02246114 - Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women N/A
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT02008292 - Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors N/A
Completed NCT01898507 - Nicotine Metabolism and Low Nicotine Cigarettes N/A
Completed NCT01954407 - Young Adults' Responses to Anti-smoking Messages N/A